Inflammatory Bowel DiseasesNCT06757231
Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel Disease
A study testing Nurse Counseling Based on the Chronic Care Model (CCM) in people with Inflammatory Bowel Diseases and Colitis, Ulcerative, run by Hasan Kalyoncu University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to evaluate the effects of nurse counseling provided based on the Chronic Care Model on symptom status, stress, and quality of life in individuals diagnosed with Inflammatory Bowel Disease (IBD). Read more about this study
- Who is it for?
- Ages 12 to 12 weeksHealthy volunteers can take part
- Conditions the study is for
- Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease
- What is being tested?
- Nurse Counseling Based on the Chronic Care Model (CCM)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 13 Feb 2024to 7 Jan 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 12 weeks
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- - Individuals diagnosed with IBD who agree to participate in the study will be included after written informed consent form and informed consent form are obtained.
- Have a confirmed diagnosis of IBD at least 6 months ago,
- No obstacles to communication,
- Can use a smartphone,
- It will be determined from volunteers who agree to participate in the research on a voluntary basis.
Who cannot join
- - IBHs for whom written consent cannot be obtained will be excluded from the study.
- Those who wish to leave the research without completing the research with their own consent,
- Patients who cannot have at least 3 interviews,
- Patients who do not show up for the appointment for the final test will not be included.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Investigation of the Effect of Nurse Counseling According to the Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel Disease
This study aims to evaluate the effects of nurse counseling provided based on the Chronic Care Model on symptom status, stress, and quality of life in individuals diagnosed with Inflammatory Bowel Disease (IBD).
Read the detailed description
nflammatory Bowel Diseases (IBD), comprising a group of chronic disorders characterized by recurrent inflammation of the gastrointestinal tract, are associated with an irregular and inappropriate immune response to intestinal flora. These diseases, which manifest with periods of remission and relapse, are classified into Ulcerative Colitis (UC), Crohn's Disease (CD), and Indeterminate Colitis (IC), where clinical differentiation between UC and CD is not clear. While the inflammatory response in UC is confined to the mucosa and submucosa, in CD, the inflammation extends through the entire intestinal wall, from the mucosa to the serosa. CD most commonly affects the distal small intestine and colon, but it can occur segmentally at any site along the gastrointestinal tract, from the mouth to the anus. Conversely, UC inflammation is typically limited to the colon and presents as diffuse superficial involvement without skipping intact segments. In some IBD cases, distinguishing between CD and UC is challenging, leading to a diagnosis of IC. These diseases demand attention due to their chronic nature and significant utilization of healthcare resources. Globally, approximately 11.2 million people are affected by IBD, with higher prevalence reported in Europe and North America. In Turkey, the incidence of IBD is reported as 2.6 per 100,000 for UC and 1.4 per 100,000 for CD.
IBD symptoms can be intestinal (gastrointestinal in origin) or extra-intestinal, resulting from associated autoimmune disorders or external manifestations of the disease. The symptoms vary depending on the activity and localization of the disease. While the major symptoms in UC and CD overlap, the severity of these symptoms differs based on the intensity of the disease. Intestinal symptoms such as diarrhea, fever, severe fatigue, abdominal pain and cramping, bloody stool, tenesmus, appetite loss, and weight loss, as well as extra-intestinal symptoms affecting various systems, can manifest with different severities in each patient. Fourie, Jackson, and Aveyard, in their review of 23 qualitative studies, highlighted fatigue, incontinence, uncertainty about the future, body image issues, and insufficient information from healthcare providers as dominant experiences among patients living with IBD.
Nurses play a crucial role in educating and empowering individuals with IBD to develop and utilize self-management skills and strategies to overcome disease-related challenges . IBD is well-suited for technological interventions, which can enhance care by involving, educating, and monitoring patients while addressing the unique manifestations of the disease in each individual.
Quality of life is a significant patient outcome indicator in both observational and interventional studies within the IBD literature . These two disease groups, characterized by periods of relapse and remission, significantly impact patients biopsychosocially, leading to disabilities and reduced quality of life. The medical management of IBD aims not only to alleviate disease symptoms but also to enhance patients' overall well-being and improve their quality of life. A study by Jelsness-Jørgensen et al. demonstrated that patient follow-up led by IBD nurses significantly improved quality-of-life scores over a year compared to traditional follow-up. Similarly, Del Hoyo et al. found that quality of life, social activity, and satisfaction levels improved across three patient groups (remotely monitored, nurse-supported telephone care, and standard face-to-face care). Effective multidisciplinary care is key to delaying relapse, prolonging remission, managing complications, and enhancing quality of life. Nurses, as part of the multidisciplinary team, play a pivotal role in supporting patients effectively in care settings outside the hospital. With appropriate management and support, they can ensure patients remain at the center of care.
Psychological comorbidities such as anxiety, depression, somatization, and perceived stress are associated with IBD, persisting not only during active disease phases but also in the absence of inflammation due to ongoing symptoms. Acute psychological issues, particularly, can exacerbate symptoms in individuals with UC by inducing systemic and mucosal pro-inflammatory responses, thereby negatively impacting the emotional dimension of quality of life in IBD patients.
Modern chronic disease care necessitates well-planned interaction between the healthcare team and patients to complement effective clinical and behavioral interventions . Consequently, various care models are employed in chronic disease management, with the Chronic Care Model (CCM) being one of the most preferred. Developed by Wagner et al. in the 1990s, the CCM serves as a guide to reduce care costs and improve quality amidst the increasing economic and social burden of chronic disease management. The CCM aims to enhance existing resources, integrate new resources, and foster a new interaction policy between well-informed patients and trained personnel. The model's key feature is its emphasis on patient-healthcare team interaction. The CCM defines six fundamental components: Community Resources and Policies, Decision Support, Healthcare Organization, Self-Management Support, Delivery System Design, and Clinical Information Systems. Among these, self-management support is central. The CCM can be utilized by healthcare professionals to ensure continuity of care, enhance collaboration and interaction between individuals and professionals, improve care quality, achieve cost-effectiveness, and facilitate active patient participation in care . The implementation of at least two components, if not all, is recommended to achieve desired outcomes. Educating patients about their diseases and effects, providing emotional and psychological support when needed, directing them to appropriate resources and information, and adopting a holistic care approach are responsibilities of nurses. Well-informed and empowered patients can succeed in self-management and take control of their disease trajectory. Numerous studies incorporating holistic nursing practices demonstrate that patient-centered interventions enhance self-management participation, improve quality of life, boost self-care skills, and activate behavioral changes. The CCM offers a general framework for better managing chronic diseases.
Supportive, qualified, and professional nursing services are essential for managing symptoms, reducing stress, and enhancing quality of life in patients with IBD. It is evident that the application of CCM-based training in IBD patients has not been extensively studied experimentally in Turkey. It is anticipated that implementing CCM-based education programs and monitoring could improve patients' symptom management, stress level control, and quality of life while increasing awareness about disease management. The outcomes of CCM implementation in IBD patients could serve as a guide for healthcare professionals, particularly nurses.
- Being tested
- Nurse Counseling Based on the Chronic Care Model (CCM)
- Keywords
- Crohn Disease, Inflamatory Bowl Disease, Ulcerative Colitis
- Medical subject headings
- Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nurse Counseling Based on the Chronic Care Model (CCM)Behavioural
Also called Chronic Care Counseling
This intervention involves personalized nurse counseling for patients diagnosed with Inflammatory Bowel Disease (IBD) based on the Chronic Care Model. The intervention includes:
Biweekly phone consultations and weekly informational messages to provide education and support for symptom management, stress reduction, and quality-of-life improvement.
An educational booklet to aid self-management. Follow-ups to assess progress, address concerns, and provide guidance on IBD management strategies.
| Study group | Role | What they receive |
|---|---|---|
| İntervention Group | Experimental | Patients in the intervention group will receive nurse counseling based on the Chronic Care Model (CCM). The intervention includes:
An initial face-to-face meeting where the patient is informed about the study, and informed consent is obtained.
Administration of scales and forms such as the Patient Information Form, IBD Activity Indices, Symptom Assessment Form, Perceived Stress Scale (PSS-14), IBD Quality of Life Scale, and the Chronic Illness Care Evaluation Scale.
Regular biweekly phone calls and weekly informational messages focusing on patient-specific needs, providing education and guidance on IBD management, and addressing any concerns.
Educational materials, including a booklet, will be provided. The nurse will also assist with managing symptoms, stress, and improving quality of life.
Follow-up evaluation at the end of 3 months with re-administration of the scales and forms. Receives: Behavioral: Nurse Counseling Based on the Chronic Care Model (CCM) |
| Control Group | Experimental | Patients in the control group will receive standard care without the enhanced counseling provided to the intervention group. The interventions include:
An initial meeting where the patient is informed about the study, and informed consent is obtained.
Administration of scales and forms such as the Patient Information Form, IBD Activity Indices, Symptom Assessment Form, Perceived Stress Scale (PSS-14), IBD Quality of Life Scale, and the Chronic Illness Care Evaluation Scale.
Reminder calls before scheduled appointments and assistance with rescheduling if needed.
Follow-up evaluation at the end of 3 months with re-administration of the scales and forms. Receives: Behavioral: Nurse Counseling Based on the Chronic Care Model (CCM) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Symptom status will be evaluated using the Inflammatory Bowel Disease Disease Activity Index .This scale measures disease activity and associated symptoms.
the impact of nursing counseling, in the patient before in Symptom Status
Measured: 12 weeks
Stress levels will be assessed using the Perceived Stress Scale (PSS-14). The PSS-14 evaluates perceived stress levels in daily life and how individuals cope with stress.
the impact of nursing counseling, in the patient before and after on the stress levels
Measured: 12 weeks
Quality of life will be assessed using the Inflammatory Bowel Disease Quality of Life scale. Changes in quality of life scores will be evaluated over time to determine improvements.
the impact of nursing counseling, in the patient before and after in Quality of Life
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jan 2025
- Study start13 Feb 2024
- Primary completion1 Jul 2024
- Study completion7 Jan 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Inflammatory Bowel DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups with a randomised controlled trial
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hasan Kalyoncu University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Seval AKBEN, Hasan Kalyoncu University
- Investigators
- seval akben, Study director, Hasan Kalyoncu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06757231
- Sponsor's protocol ID
- HKÜ-SAKBEN-2023/73
- Status last verified
- Dec 2024
- First submitted
- 19 May 2024
- Last updated
- 3 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Effect of Nurse Counseling According to the Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel Disease
- ClinicalTrials.gov ID
- NCT06757231
- Acronym / sponsor ID
- HKÜ-SAKBEN-2023/73
- Keywords
- Crohn Disease, Inflamatory Bowl Disease, Ulcerative Colitis
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Hasan Kalyoncu UniversityUniversity, hospital or other
- Study start
- 13 Feb 2024 (actual)
- Primary completion
- 1 Jul 2024 (actual)
- Study completion
- 7 Jan 2025 (estimated)
- First posted
- 3 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effects of nurse counseling provided based on the Chronic Care Model on symptom status, stress, and quality of life in individuals diagnosed with Inflammatory Bowel Disease (IBD).
Detailed description
nflammatory Bowel Diseases (IBD), comprising a group of chronic disorders characterized by recurrent inflammation of the gastrointestinal tract, are associated with an irregular and inappropriate immune response to intestinal flora. These diseases, which manifest with periods of remission and relapse, are classified into Ulcerative Colitis (UC), Crohn's Disease (CD), and Indeterminate Colitis (IC), where clinical differentiation between UC and CD is not clear. While the inflammatory response in UC is confined to the mucosa and submucosa, in CD, the inflammation extends through the entire intestinal wall, from the mucosa to the serosa. CD most commonly affects the distal small intestine and colon, but it can occur segmentally at any site along the gastrointestinal tract, from the mouth to the anus. Conversely, UC inflammation is typically limited to the colon and presents as diffuse superficial involvement without skipping intact segments. In some IBD cases, distinguishing between CD and UC is challenging, leading to a diagnosis of IC. These diseases demand attention due to their chronic nature and significant utilization of healthcare resources. Globally, approximately 11.2 million people are affected by IBD, with higher prevalence reported in Europe and North America. In Turkey, the incidence of IBD is reported as 2.6 per 100,000 for UC and 1.4 per 100,000 for CD.
IBD symptoms can be intestinal (gastrointestinal in origin) or extra-intestinal, resulting from associated autoimmune disorders or external manifestations of the disease. The symptoms vary depending on the activity and localization of the disease. While the major symptoms in UC and CD overlap, the severity of these symptoms differs based on the intensity of the disease. Intestinal symptoms such as diarrhea, fever, severe fatigue, abdominal pain and cramping, bloody stool, tenesmus, appetite loss, and weight loss, as well as extra-intestinal symptoms affecting various systems, can manifest with different severities in each patient. Fourie, Jackson, and Aveyard, in their review of 23 qualitative studies, highlighted fatigue, incontinence, uncertainty about the future, body image issues, and insufficient information from healthcare providers as dominant experiences among patients living with IBD.
Nurses play a crucial role in educating and empowering individuals with IBD to develop and utilize self-management skills and strategies to overcome disease-related challenges . IBD is well-suited for technological interventions, which can enhance care by involving, educating, and monitoring patients while addressing the unique manifestations of the disease in each individual.
Quality of life is a significant patient outcome indicator in both observational and interventional studies within the IBD literature . These two disease groups, characterized by periods of relapse and remission, significantly impact patients biopsychosocially, leading to disabilities and reduced quality of life. The medical management of IBD aims not only to alleviate disease symptoms but also to enhance patients' overall well-being and improve their quality of life. A study by Jelsness-Jørgensen et al. demonstrated that patient follow-up led by IBD nurses significantly improved quality-of-life scores over a year compared to traditional follow-up. Similarly, Del Hoyo et al. found that quality of life, social activity, and satisfaction levels improved across three patient groups (remotely monitored, nurse-supported telephone care, and standard face-to-face care). Effective multidisciplinary care is key to delaying relapse, prolonging remission, managing complications, and enhancing quality of life. Nurses, as part of the multidisciplinary team, play a pivotal role in supporting patients effectively in care settings outside the hospital. With appropriate management and support, they can ensure patients remain at the center of care.
Psychological comorbidities such as anxiety, depression, somatization, and perceived stress are associated with IBD, persisting not only during active disease phases but also in the absence of inflammation due to ongoing symptoms. Acute psychological issues, particularly, can exacerbate symptoms in individuals with UC by inducing systemic and mucosal pro-inflammatory responses, thereby negatively impacting the emotional dimension of quality of life in IBD patients.
Modern chronic disease care necessitates well-planned interaction between the healthcare team and patients to complement effective clinical and behavioral interventions . Consequently, various care models are employed in chronic disease management, with the Chronic Care Model (CCM) being one of the most preferred. Developed by Wagner et al. in the 1990s, the CCM serves as a guide to reduce care costs and improve quality amidst the increasing economic and social burden of chronic disease management. The CCM aims to enhance existing resources, integrate new resources, and foster a new interaction policy between well-informed patients and trained personnel. The model's key feature is its emphasis on patient-healthcare team interaction. The CCM defines six fundamental components: Community Resources and Policies, Decision Support, Healthcare Organization, Self-Management Support, Delivery System Design, and Clinical Information Systems. Among these, self-management support is central. The CCM can be utilized by healthcare professionals to ensure continuity of care, enhance collaboration and interaction between individuals and professionals, improve care quality, achieve cost-effectiveness, and facilitate active patient participation in care . The implementation of at least two components, if not all, is recommended to achieve desired outcomes. Educating patients about their diseases and effects, providing emotional and psychological support when needed, directing them to appropriate resources and information, and adopting a holistic care approach are responsibilities of nurses. Well-informed and empowered patients can succeed in self-management and take control of their disease trajectory. Numerous studies incorporating holistic nursing practices demonstrate that patient-centered interventions enhance self-management participation, improve quality of life, boost self-care skills, and activate behavioral changes. The CCM offers a general framework for better managing chronic diseases.
Supportive, qualified, and professional nursing services are essential for managing symptoms, reducing stress, and enhancing quality of life in patients with IBD. It is evident that the application of CCM-based training in IBD patients has not been extensively studied experimentally in Turkey. It is anticipated that implementing CCM-based education programs and monitoring could improve patients' symptom management, stress level control, and quality of life while increasing awareness about disease management. The outcomes of CCM implementation in IBD patients could serve as a guide for healthcare professionals, particularly nurses.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Two groups with a randomised controlled trial
| Arm | Type | Receives |
|---|---|---|
| İntervention Group | Experimental | Behavioral: Nurse Counseling Based on the Chronic Care Model (CCM)Patients in the intervention group will receive nurse counseling based on the Chronic Care Model (CCM). The intervention includes: An initial face-to-face meeting where the patient is informed about the study, and informed consent is obtained. Administration of scales and forms such as the Patient Information Form, IBD Activity Indices, Symptom Assessment Form, Perceived Stress Scale (PSS-14), IBD Quality of Life Scale, and the Chronic Illness Care Evaluation Scale. Regular biweekly phone calls and weekly informational messages focusing on patient-specific needs, providing education and guidance on IBD management, and addressing any concerns. Educational materials, including a booklet, will be provided. The nurse will also assist with managing symptoms, stress, and improving quality of life. Follow-up evaluation at the end of 3 months with re-administration of the scales and forms. |
| Control Group | Experimental | Behavioral: Nurse Counseling Based on the Chronic Care Model (CCM)Patients in the control group will receive standard care without the enhanced counseling provided to the intervention group. The interventions include: An initial meeting where the patient is informed about the study, and informed consent is obtained. Administration of scales and forms such as the Patient Information Form, IBD Activity Indices, Symptom Assessment Form, Perceived Stress Scale (PSS-14), IBD Quality of Life Scale, and the Chronic Illness Care Evaluation Scale. Reminder calls before scheduled appointments and assistance with rescheduling if needed. Follow-up evaluation at the end of 3 months with re-administration of the scales and forms. |
Who may qualify
- Ages
- 12 to 12 weeks
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (5 listed)
- - Individuals diagnosed with IBD who agree to participate in the study will be included after written informed consent form and informed consent form are obtained.
- Have a confirmed diagnosis of IBD at least 6 months ago,
- No obstacles to communication,
- Can use a smartphone,
- It will be determined from volunteers who agree to participate in the research on a voluntary basis.
Key exclusion criteria (4 listed)
- - IBHs for whom written consent cannot be obtained will be excluded from the study.
- Those who wish to leave the research without completing the research with their own consent,
- Patients who cannot have at least 3 interviews,
- Patients who do not show up for the appointment for the final test will not be included.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Nurse Counseling Based on the Chronic Care Model (CCM)Also: Chronic Care CounselingThis intervention involves personalized nurse counseling for patients diagnosed with Inflammatory Bowel Disease (IBD) based on the Chronic Care Model. The intervention includes: Biweekly phone consultations and weekly informational messages to provide education and support for symptom management, stress reduction, and quality-of-life improvement. An educational booklet to aid self-management. Follow-ups to assess progress, address concerns, and provide guidance on IBD management strategies. | Behavioural | Control Group, İntervention Group |
Primary outcome
Symptom status will be evaluated using the Inflammatory Bowel Disease Disease Activity Index .This scale measures disease activity and associated symptoms.
Time frame: 12 weeks
the impact of nursing counseling, in the patient before in Symptom Status
Stress levels will be assessed using the Perceived Stress Scale (PSS-14). The PSS-14 evaluates perceived stress levels in daily life and how individuals cope with stress.
Time frame: 12 weeks
the impact of nursing counseling, in the patient before and after on the stress levels
Quality of life will be assessed using the Inflammatory Bowel Disease Quality of Life scale. Changes in quality of life scores will be evaluated over time to determine improvements.
Time frame: 12 weeks
the impact of nursing counseling, in the patient before and after in Quality of Life
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jan 2025.
- Individual participant dataSharing planned: No
Related trials for Inflammatory Bowel Diseases
Not yet recruitingObservational study
Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease
Inflammatory Bowel Diseases (IBD), Crohn Disease
Recruiting
Multi-omics Dissection of Gut Microbiome Engraftment During FMT
Recurrent C. Difficile (rCDI), Ulcerative Colitis (UC)
RecruitingPhase 4
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Crohn Disease
Not yet recruiting
Online Pain Education for Crohn's Disease and Ulcerative Colitis
Crohn's Disease, Ulcerative Colitis (UC)
RecruitingObservational study
Immune Regulation in Ulcerative Colitis or Crohn s Disease
Inflammatory Bowel Disease, Ulcerative Colitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
seval akben study director
Hasan Kalyoncu University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Nurse Counseling Based on the Chronic Care Model (CCM) in people with Inflammatory Bowel Diseases and Colitis, Ulcerative, run by Hasan Kalyoncu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Symptom status will be evaluated using the Inflammatory Bowel Disease Disease Activity Index .This scale measures disease activity and associated symptoms. (time frame: 12 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.